SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Fowkes F. Gerry R.)
 

Sökning: WFRF:(Fowkes F. Gerry R.) > A Structured Review...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004396naa a2200445 4500
001oai:lup.lub.lu.se:28a6923d-981f-42f0-ae16-4bbe5d9fdba3
003SwePub
008170811s2017 | |||||||||||000 ||eng|
024a https://lup.lub.lu.se/record/28a6923d-981f-42f0-ae16-4bbe5d9fdba32 URI
024a https://doi.org/10.1161/CIRCULATIONAHA.117.0244692 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a for2 swepub-publicationtype
072 7a ref2 swepub-contenttype
100a Hess, Connie N.u University of Colorado School of Medicine4 aut
2451 0a A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease with a Focus on Revascularization : A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative
264 1c 2017
300 a 22 s.
520 a Peripheral artery disease affects >200 million people worldwide and is associated with significant limb and cardiovascular morbidity and mortality. Limb revascularization is recommended to improve function and quality of life for symptomatic patients with peripheral artery disease with intermittent claudication who have not responded to medical treatment. For patients with critical limb ischemia, the goals of revascularization are to relieve pain, help wound healing, and prevent limb loss. The baseline risk of cardiovascular and limb-related events demonstrated among patients with stable peripheral artery disease is elevated after revascularization and related to atherothrombosis and restenosis. Both of these processes involve platelet activation and the coagulation cascade, forming the basis for the use of antiplatelet and anticoagulant therapies to optimize procedural success and reduce postprocedural cardiovascular risk. Unfortunately, few high-quality, randomized data to support use of these therapies after peripheral artery disease revascularization exist, and much of the rationale for the use of antiplatelet agents after endovascular peripheral revascularization is extrapolated from percutaneous coronary intervention literature. Consequently, guideline recommendations for antithrombotic therapy after lower limb revascularization are inconsistent and not always evidence-based. In this context, the purpose of this structured review is to assess the available randomized data for antithrombotic therapy after peripheral arterial revascularization, with a focus on clinical trial design issues that may affect interpretation of study results, and highlight areas that require further investigation.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
653 a antithrombotic
653 a peripheral artery disease
653 a revascularization
700a Norgren, Larsu Lund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Department of Clinical Sciences, Malmö,Faculty of Medicine4 aut0 (Swepub:lu)kir-lno
700a Ansel, Gary M.u Örebro University4 aut
700a Capell, Warren H.u University of Colorado School of Medicine4 aut
700a Fletcher, John P.u University of Colorado School of Medicine4 aut
700a Fowkes, F. Gerry R.u University of Sydney4 aut
700a Gottsäter, Andersu Lund University,Lunds universitet,Vaskulära sjukdomar - kliniska studier,Forskargrupper vid Lunds universitet,Vascular Diseases - Clinical Research,Lund University Research Groups,University of Edinburgh4 aut0 (Swepub:lu)medf-ago
700a Hitos, Kerryu Skåne University Hospital,Lund University4 aut
700a Jaff, Michael R.u University of Sydney4 aut
700a Nordanstig, Joakimu Harvard Medical School4 aut
700a Hiatt, William R.u University of Colorado School of Medicine,Sahlgrenska University Hospital4 aut
710a University of Colorado School of Medicineb Institutionen för kliniska vetenskaper, Malmö4 org
773t Circulationg 135:25, s. 2534-2555q 135:25<2534-2555x 0009-7322
856u http://dx.doi.org/10.1161/CIRCULATIONAHA.117.024469y FULLTEXT
8564 8u https://lup.lub.lu.se/record/28a6923d-981f-42f0-ae16-4bbe5d9fdba3
8564 8u https://doi.org/10.1161/CIRCULATIONAHA.117.024469

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy